![](https://investorshub.advfn.com/uicon/32556.png?cb=1490101632)
Wednesday, January 06, 2016 9:58:22 AM
Jan9: AACR's The Function of Tumor Microenvironment in Cancer Progression Conf., SanDiego http://tinyurl.com/oo37gwr
...Dr. Rolf Brekken (UTSW, PPHM SAB): “Antibody mediated blockade of PS synergizes with immune checkpoint blockade by inhibiting multiple immune suppressive mechanisms”
.....note: the chair in Dr.Brekken's “Actions of Innate & Adaptive Immunity” session is Dr. Joan Massague, DIRECTOR of The Memorial Sloan Kettering Inst.
Jan25: Phacilitate's Immunotherapy World Conf., WashDC http://tinyurl.com/zjd7h4n
...3:40-3:55pm, Dr. Jeff Hutchins (VP/PreClinRes): “Combination Immunotherapies - Opening the Gate: Increasing Tumor Infiltrating Activated T-cells to Optimize & Expand the Benefits of Immune Checkpoint Therapies”
Jan26: GTCbio's Novel Immunotherapeutics Summit, San Diego http://tinyurl.com/z3dyful
...10am, Dr. Bruce Freimark (ResDir./Preclin.Oncology): “Blockade of PS Enhances the Anti-Tumor Activity of Targeted Therapy & Immune Checkpoint Inhibitors by Reducing Immunosuppressive Cells in the Tumor Microenvironment”
Jan26-28/Avid/Booth20: CASSS' 20th Symposium on the Interface of Reg.&Anal. Sciences for Biotech Health Products, WashDC http://www.casss.org/?WCBP1600
Mar8: CHI’s Inaugural Cancer Immunotherapy Conf., SanFran http://tinyurl.com/hlskng8
...3:55pm, Dr. Jeff Hutchins (VP/PreClinRes), Track Chair: “Combination Immunotherapies – Opening the Gate: Increasing Tumor Infiltrating Activated T-Cells to Optimize & Expand the Benefits of Immune Checkpoint Therapies”
~Mar10: FY'16Q3 (qe 1-31-16) Financials & Conf. Call http://ir.peregrineinc.com/events.cfm
Mar14-17/Avid/Booth712: IBC's BioProcess Intl. West, Oakland http://www.ibclifesciences.com/BPIWest/overview.xml
Mar16: Immune Checkpoint Inhibitors Conf., Boston http://tinyurl.com/hzjjs2u (Peregrine is 1 of 8 Corp. Sponsors)
...2pm, Dr. Jeff Hutchins (VP/PreClinRes): “Enhancing the Power of Checkpoint Inhibition by Simultaneously Blocking Upstream & Downstream Targets: The Role of PS, a Novel, Global Immune Checkpoint”
??Apr16-20: AACR 2016, New Orleans http://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=63
??Jun3-7: ASCO 2016, Chicago http://am.asco.org
Jun6-9/Avid/Booth5562: BIO Intl. Convention, SanFran http://convention.bio.org
~Jul12: FY'16Q4 (fy/e 4-30-16) Financials & Conf. Call http://ir.peregrineinc.com/events.cfm
Recent CDMO News
- Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024 • GlobeNewswire Inc. • 07/02/2024 08:05:04 PM
- Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 • GlobeNewswire Inc. • 07/01/2024 11:00:21 AM
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM